Press release
Robust Growth in the Rare Neurological Disease Treatment Market: Key Statistics, Predominant Drivers, Major Players, and Market Trends
Rare Neurological Disease Treatment Market Share
The global market for rare neurological disease treatment is witnessing rapid expansion and is anticipated to grow at an impressive CAGR, spurred by cutting-edge advancements and trends in the industry.
What Is The Projected Market Size Of The Global Rare Neurological Disease Treatment Market And Its Growth Rate?
• Historical Market Growth: The market size for rare neurological disease treatment has been burgeoning. From $9.85 billion in 2024, it surged to $10.68 billion in 2025 at a CAGR of 8.4%. This substantial growth was propelled by factors such as the advent of biosimilars in rare disease treatment, globalization of clinical trials, favorable healthcare reimbursement policies, orphan drug designations, and advancements in genetic research.
• Future Market Growth: Analysts predict that this robust growth trend will continue in the coming years. The market is slated to reach $14.84 billion in 2029, expanding at a CAGR of 8.6%. The key drivers for this virtuous growth cycle include improved diagnostic tools, advancements in precision medicine, patient-centric drug development, integration of real-world evidence, telemedicine for patient support, and a shift towards personalized therapies.
What Is Driving The Growth In The Rare Neurological Disease Treatment Market?
A significant increase in the prevalence of rare neurological diseases is fostering the growth of the rare neurological disease treatment market. These low-prevalence disorders, including Huntington's disease, ALS, Rett syndrome, and several forms of muscular dystrophy, necessitate treatment strategies that manage symptoms, slow disease progression, and enhance the quality of life for affected individuals. For example, an article published by BioMed Central Ltd in January 2023 reported that Rett syndrome had a collective prevalence of 7.1 per 100,000 females in a combined sample size of 9.57 million women, confirming 673 cases. The rising prevalence of these rare neurological diseases is a major driver for the growth of this treatment market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12146&type=smp
Who Are the Key Players Driving Rare Neurological Disease Treatment Market Growth?
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• F. Hoffmann-La Roche Ltd
• Bayer AG
• Merck & Co. Inc.
• AbbVie Inc.
• Novartis AG
• Sanofi-Aventis SA
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Medtronic PLC
• Teva Pharmaceutical Industries Ltd.
• CSL Limited
• Biogen Inc.
• UCB S.A.
• Eisai Co. Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Jazz Pharmaceuticals PLC
• Mitsubishi Tanabe Pharma Corporation
• Neurocrine Biosciences Inc.
• Kedrion Biopharma Inc.
• Merz Pharma GmbH & Co. KGaA
• Harmony Biosciences Holdings Inc.
• Amicus Therapeutics Inc.
• Revance Therapeutics Inc.
• Aquestive Therapeutics Inc.
• US WorldMeds LLC (Solstice Neurosciences LLC)
• Stoke Therapeutics Inc.
• Retrotope Inc.
What Are The Key Trends In The Rare Neurological Disease Treatment Market?
• Technological Innovations
• AI in Drug Discovery
• Blockchain for Data Security
• Machine Learning in Drug Discovery
What Are The Segments Of The Global Rare Neurological Disease Treatment Market?
• Drug Type: Biologics, Small Molecules
• Therapy: Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Cyberknife, Other Therapies
• Mode Of Administration: Oral, Injectable, Other Modes Of Administration
• Disorders: Aicardi Syndrome, Aicardi-Goutières Syndrome, Reflex Sympathetic Dystrophy Syndrome, Battaglia-Neri Syndrome, Creutzfeldt Jakob Disease, Agnosia, Other Disorders
• Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Store, Online Pharmacies
What Region Leads The Rare Neurological Disease Treatment Market?
North America was the largest market for rare neurological diseases treatment in 2024. However, the Asia-Pacific region is expected to register the highest growth rate in the forecast period. Other regions covered in the report include Western Europe, Eastern Europe, South America, the Middle East, and Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report
What Is Covered In The Rare Neurological Disease Treatment Market Global Market Report?
- Market Size Analysis: Analyze the Rare Neurological Disease Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Rare Neurological Disease Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Rare Neurological Disease Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Rare Neurological Disease Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12146&type=smp
Learn More About The Business Research Company:
The Business Research Company, a leading provider of market research reports, offers comprehensive insights over 27 industries spanning 60+ geographies. Backed by unique insights from industry leaders, coupled with 1,500,000 data sets, and powered by in-depth secondary research, the company has built a reputation for delivering data-rich research and insights. Its flagship product, the Global Market Model (GMM), is a high-quality market intelligence platform offering updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Robust Growth in the Rare Neurological Disease Treatment Market: Key Statistics, Predominant Drivers, Major Players, and Market Trends here
News-ID: 3836889 • Views: …
More Releases from The Business research company
Global Semantic Knowledge Graphing Market Projected to Grow at 12.5% CAGR, Reach …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Semantic Knowledge Graphing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been significant growth in the market size of semantic knowledge graphing. It is anticipated that the market will expand from $1.49 billion in 2024 to $1.7 billion in 2025,…
Global Security Analytics Industry Outlook 2025-2029: Market Set to Cross $35.7 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Security Analytics Market Through 2025?
The market size for security analytics has rapidly expanded in the recent past. From $17 billion in 2024, it is projected to swell up to $19.74 billion in 2025, representing a compound annual growth rate (CAGR) of…
Remote Work Revolution Fueling The Surge In Robotic Process Automation (RPA) Tec …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Robotic Process Automation (RPA) In Information Technology Industry Market Size Be by 2025?
The market size of Robotic Process Automation (RPA) in Information Technology has seen an explosive growth recently. The market is projected to expand from $1.42 billion in 2024 to $1.78 billion in 2025,…
Soaring Demand Set to Propel Remote Firmware Market to $13.58 Billion by 2029
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Remote Firmware Market Size By 2025?
The market size of remote firmware has experienced substantial growth in the past few years. It is projected to increase from $7.35 billion in 2024 to $8.37 billion in 2025, with a compound annual growth rate (CAGR) of 13.8%.…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
